Eli Lilly reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Eli Lilly using advanced sorting and filters.
Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
---|---|---|---|---|
Sep 2024 | 2024-10-30 | $1.18 | $1.45 | -18.6 % |
Jun 2024 | 2024-08-08 | $3.92 | $2.70 | 45.2 % |
Mar 2024 | 2024-04-30 | $2.58 | $2.46 | 4.88 % |
Dec 2023 | 2024-02-06 | $2.49 | $2.19 | 13.7 % |
Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
---|---|---|---|---|
Sep 2024 | 2024-10-30 | $11.44B | $12.10B | -5.46 % |
Jun 2024 | 2024-08-08 | $11.30B | $9.95B | 13.6 % |
Mar 2024 | 2024-04-30 | $8.77B | $8.92B | -1.70 % |
Dec 2023 | 2024-02-06 | $9.35B | $8.93B | 4.74 % |
Eli Lilly (LLY) is scheduled to report earnings on February 4, 2025. The last reported earnings were for reported on October 30, 2024 for Q3.
The Actual EPS was $1.18, which missed the estimate of $1.45.
The Actual Revenue was $11.4B, which missed the estimate of $12.1B.
Browse earnings estimates, EPS, and revenue on all stocks.